Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin - 09/08/11
, Marwan Al-Khawajah, MD a, Omar Al-Sheikh, MD a, Fahad Al-Saif, MD a, Saleh Al-Rasheed, MD a, Ibrahim Al-Hoqail, MD a, Issam R. Hamadah, MD b
Reprint requests: Abdulmajeed Alajlan, MD, Dermatology Department, Faculty of Medicine, King Saud University, PO Box 7805, Riyadh 11472 Saudi Arabia.Riyadh, Saudi Arabia
Abstract |
Background |
Linear IgA bullous dermatosis of childhood is a rare autoimmune bullous disease that mainly affects preschool-aged children. Dapsone is considered the first-line therapy with prompt response from most patients. However, it may be contraindicated in certain conditions such as glucose-6-phosphate dehydrogenase deficiency.
Objective |
We sought to assess the efficacy of flucloxacillin in the treatment of linear IgA bullous dermatosis.
Methods |
This is an observational study in which all confirmed cases of linear IgA bullous dermatosis (by both histological and immunofluorescence studies) will be treated with flucloxacillin. Flucloxacillin will be continued according to the response or otherwise will be discontinued after 8 weeks in the case of resistance.
Results |
We describe 7 patients with linear IgA bullous dermatosis of childhood treated with flucloxacillin. In 4 cases, it induced complete remission within 3 to 4 months of starting therapy with no relapses. In the other 3 cases, it successfully controlled the disease but with prompt relapse on discontinuation of the treatment.
Limitations |
This is a case series study with a small number of patients.
Conclusion |
Flucloxacillin may be considered among the first alternative therapies for linear IgA bullous dermatosis of childhood. Further evaluation of the efficacy and safety of the long-term use is required.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. Conflicts of interest: None identified. |
Vol 54 - N° 4
P. 652-656 - avril 2006 Retour au numéro
Article précédent
- Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate
- Stine Regin Wiegell, Hans Christian Wulf
- Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient
- Eun Ji Kwon, Kenneth A. Katz, Karla S. Draft, John T. Seykora, Alain H. Rook, Mariusz A. Wasik, Jacqueline M. Junkins-Hopkins
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?